Lantern Pharma (LTRN) vs Processa Pharmaceuticals (PCSA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Processa Pharmaceuticals is the larger company by market cap ($4.4 million vs $3.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LTRN | PCSA |
|---|---|---|
| Share price | $0.245 | $1.56 |
| Market cap | $3.89M | $4.37M |
| 1-day change | -13.73% | -7.69% |
| YTD return | -91.91% | — |
| 1-year return | -91.89% | — |
| 5-year return | -97.27% | — |
| EPS (TTM) | $-1.44 | $-68.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-17.12M | $-13.56M |
| 52-week high | $4.34 | $8.88 |
| 52-week low | $0.2286 | $1.04 |
| Distance from 52-week high | -94.35% | -82.43% |
| Analyst consensus | none | — |
| Avg. price target upside | +7042.86% | — |
| Average volume | 249.66K | 79.50K |
| Shares outstanding | 15.89M | 2.80M |
| Employees | 16 | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lantern Pharma
LTRN stock →Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India.
Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees
About Processa Pharmaceuticals
PCSA stock →Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
LTRN vs PCSA FAQ
Which is bigger, Lantern Pharma or Processa Pharmaceuticals?
Processa Pharmaceuticals (PCSA) is larger, with a market capitalization of $4.37M compared with $3.89M for Lantern Pharma (LTRN).
Are Lantern Pharma and Processa Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.